miR-326 inhibits the progression of papillary thyroid carcinoma by targeting MAPK1 and ERBB4

JOURNAL ARTICLE published 2020 in Neoplasma

Authors: F.R. NIE | Q.X. LI | H.F. WEI | Y. MA